When Will ElevenLabs IPO? CEO Won't Deny a 2028 Target

Start from $25 → · Request ElevenLabs Allocation → · Stripe checkout (Card, Apple Pay, Link · no password · terms).

Just researching? Get free ElevenLabs mark alerts by email

Free tracker, email only. No card, no documents. Or start from $25 on Stripe →

As of September 26, 2026, ElevenLabs has not filed a registration statement for an initial public offering; no Form S-1 appears for the company on SEC EDGAR, the U.S. Securities and Exchange Commission's public filing database, which covers only U.S. securities filings and would not reflect a listing filed with a non-U.S. regulator or exchange. Bloomberg reported via the Reuters wire on July 2, 2026 that ElevenLabs was exploring an employee stock sale at a valuation of roughly $22 billion, a liquidity event for existing shareholders that is separate from an IPO. More recently, when TechCrunch directly asked ElevenLabs CEO Mati Staniszewski on September 24, 2026 to confirm reports that the company is "looking at 2028 for an IPO," he did not deny it, saying: "We are preparing the foundation to be able to do it in the next years. But whether we do it will depend on the time and place." That is preparation, not a committed date, and no filing has followed the remark.

Educational pre-IPO guide. Share allocations and secondary transactions are subject to eligibility and private settlement terms.

Start ElevenLabs from $25 →

Key points

A stock sale is not a listing

Bloomberg reported on July 2, 2026, via the Reuters wire, that ElevenLabs was exploring an employee stock sale at a valuation of roughly $22 billion. An employee stock sale lets current staff or early shareholders sell existing shares to investors; it moves money between private parties and does not create publicly tradable stock.

That kind of transaction is separate from an initial public offering. It requires no registration statement, no prospectus, and no review by a securities regulator, so its existence says nothing on its own about whether or when ElevenLabs intends to list on an exchange.

The CEO did not say no

On September 24, 2026, TechCrunch asked ElevenLabs CEO Mati Staniszewski directly to confirm reports that the company is 'looking at 2028 for an IPO.' He did not deny it, replying: "We are preparing the foundation to be able to do it in the next years. But whether we do it will depend on the time and place."

That is a statement about preparation, not a commitment. It names no filing date, no exchange, and no underwriter, and it explicitly conditions any IPO on future timing and circumstances that Staniszewski described as undetermined.

What a filing would look like, and what has not happened

A US initial public offering requires a Form S-1 registration statement filed with the SEC and published on SEC EDGAR, the agency's public filing database. As of September 26, 2026, no such filing exists for ElevenLabs on EDGAR. EDGAR covers only US securities filings, so it would not show a listing filed with a different national regulator or exchange either.

Until a filing appears, or ElevenLabs or a regulator states a specific date, any 'ElevenLabs IPO date' circulating online remains speculation. Track SEC EDGAR and ElevenLabs' own statements directly rather than secondary rumors.

Private-share data lens

Public round-by-round marks are incomplete for this company. Segmara shows the listing mark and keeps the seed-to-IPO analysis focused on verifiable funding, tender, or secondary signals.

Segmara markNo indicative price yet

Indicative listing context

StageDateValuation / price signalWhy it matters
Seed / earlyPrivateNot reliably publicDo not invent a seed price when the source set is thin.
Growth roundsPrivateCompany and market sources varyUse public sources and official company releases.
Segmara listingCurrentNo indicative price yetIndicative reference only, not a quote or an offer.
IPO statusCurrentNo public ticker shown hereWatch official company releases and the free Segmara IPO calendar.

Seed-to-IPO path

Illustrative completeness map. Longer bars mean stronger public data or more useful current pricing context, not lower risk.

Early data22%
Growth data46%
Segmara mark68%
IPO/public18%
Start ElevenLabs from $25 →

AI-ready data summary

A structured extraction layer for this article: catalogue numbers, price context, chart values, and route-specific facts that search and AI systems can read directly from the page.

MetricValueContext
Canonical route/blog/when-will-elevenlabs-ipoStable URL path for AI and search extraction.
Article titleWhen Will ElevenLabs IPO? CEO Won't Deny a 2028 TargetMain page topic.
Attached public sources2Number of citation links rendered at the bottom of the article.
Segmara listed companies148Live private-company listings in the public catalogue.
Priced listings37Catalogue listings with visible indicative or direct marks.
Listings without an indicative price111Catalogue listings where a public price is intentionally not invented.
CompanyElevenLabsNamed company covered by this page.
Symbol labelELVNSegmara display symbol; not a public stock ticker unless separately stated.
SectorArtificial IntelligenceCatalogue sector used for comparison and internal linking.
Listing structureRequestHow the listing is categorized on Segmara.
Segmara markNo indicative price yetVisible listing mark, or no indicative price yet.
Sector peer count14Number of live Segmara listings in Artificial Intelligence.
Structure peer count111Number of live Segmara listings categorized as Request.
StageTimingPrice / valuation signalInterpretation
FormationPrivateEarly ownershipThe first value creation happens before ordinary public-market access.
Growth roundsPrivateInstitutional repricingLater rounds and tenders create the price history buyers study.
Segmara listingCurrentNo indicative price yetIndicative reference only, not a quote or an offer.
Exit pathFutureIPO, tender, acquisition, or continued private statusLiquidity timing remains company-specific.
Chart metricScoreInterpretation
Start ElevenLabs from $25 →

Analytical lens

Search intent

Searches like 'When Will ElevenLabs IPO? CEO Won't Deny a 2028 Target' are research questions: what a filing or a company statement confirms, what has only been reported, and what is still unknown.

What counts as a listing step

For an IPO, the primary record is a registration statement filed with the securities regulator of the listing market, such as an S-1 or F-1 on SEC EDGAR for a US listing. Funding rounds, valuations and secondary-market prices are context, not listing steps.

Segmara role

Segmara takes reviewed pre-IPO allocation requests funded by Stripe USD credits from $25 ($1.00 starter credit); no allocation is guaranteed. It also publishes dated indicative reference marks across 140+ private companies. Nothing on this page is investment advice.

How pre-IPO share access works

Standard Segmara allocation path

1. SearchStart with the company or pre-IPO question
2. ListingReview indicative mark and structure context
3. CheckoutFund from $25 ($1 starter credit) via Stripe, no password
4. ReviewEach request is reviewed in your dashboard; no allocation is guaranteed

What happens after payment

Indicative mark & listing selectionPublic
No-password StripeFrom $25 / $1 credit
Share allocation requestDirect
Transfer & settlement termsReviewed, not guaranteed
Start ElevenLabs from $25 →

Key takeaways

Risk notes

Public source links

PRE-IPO ALLOCATION

Request ElevenLabs pre-IPO shares

Start from $25 in USD portfolio credits via Stripe (no password required) and request a pre-IPO share allocation in ElevenLabs.

Start ElevenLabs from $25 →

1-unit requests under $20: Aalo ($1.00) · ID.me ($1.40) · Chainalysis ($6.20) · Precision ($8.18) · Scale AI ($8.78) · Huntress ($19.03)

Explore all pre-IPO listingsFund portfolio credits

Questions

Can investors request private-company shares on Segmara?

Yes. Start from $25 ($1.00 starter credit available) in USD portfolio credits via Stripe with no password required, or select a listing across 140+ private companies on Segmara to submit a pre-IPO share allocation request.

Why was this market historically hard for individual investors to reach?

Private-company share access has often moved through private equity firms, venture funds, insiders, institutions, and relationship-driven secondary networks. Segmara makes the starting point simpler: browse 140+ named private-company listings, fund USD credits via Stripe from $25 ($1.00 starter credit), and request share allocations with no password wall.

What is the easiest next step?

Start from $25 ($1.00 starter credit available) via instant Stripe checkout (Card, Apple Pay, Link, no password required), or browse Segmara's live pre-IPO listings to select your target company.

Has ElevenLabs confirmed an IPO date?

No. As of the latest site review, no Form S-1 or other registration statement has been filed with the SEC or any other regulator. When TechCrunch asked CEO Mati Staniszewski directly on September 24, 2026 whether a reported 2028 target was accurate, he did not deny it but did not name a date either, saying: "We are preparing the foundation to be able to do it in the next years. But whether we do it will depend on the time and place."

What is ElevenLabs worth?

The most recent figure comes from Bloomberg, reported via the Reuters wire on July 2, 2026: ElevenLabs was said to be exploring an employee stock sale at a valuation of roughly $22 billion. That figure is tied to a specific transaction reportedly under discussion, not an audited or company-confirmed valuation.

Is an employee stock sale the same as an IPO?

No. An employee stock sale, often called a tender offer, lets current employees or early shareholders sell existing shares to investors in a private transaction. It does not involve a public listing, a stock exchange, or a registration statement filed with a securities regulator. The July 2026 report describes this kind of private sale, not a public offering.

Can I buy ElevenLabs shares before the IPO?

Not through a public exchange, since ElevenLabs has not filed to go public. Any private-share offer you encounter should be verified independently before you rely on it. Segmara does not sell, broker, or arrange purchases of ElevenLabs shares.

Pre-IPO Allocation

Request ElevenLabs shares on Segmara.

Start from $25 ($1 starter credit available) via Stripe with no password required, fund USD portfolio credits, and request a pre-IPO allocation in ElevenLabs.

Request ElevenLabs Allocation →

1-unit requests under $20: Aalo ($1.00) · ID.me ($1.40) · Chainalysis ($6.20) · Precision ($8.18) · Scale AI ($8.78) · Huntress ($19.03)

Explore 140+ pre-IPO listings · Custom credit amount

Start ElevenLabs from $25 →